K. Thomas  Bailey net worth and biography

K. Bailey Biography and Net Worth

K. Thomas Bailey has served as Chief Financial Officer since January 2018. Prior to joining our company, Mr. Bailey was Chief Financial Officer at AgaMatrix Holdings LLC, a developer, manufacturer and marketer of medical technologies for diabetes care, from March 2014 to January 2018. Prior to joining AgaMatrix, Mr. Bailey served as Chief Executive Officer of Angiotech Pharmaceuticals, a developer, manufacturer and marketer of local drug, drug delivery and medical device technologies, from October 2011 to October 2013, and served as Angiotech’s Chief Financial Officer from December 2005 to October 2011. During his time as CFO of Angiotech, Mr. Bailey directed a restructuring of Angiotech’s debt obligations pursuant to the Canadian Creditors Arrangement Act in 2011, with recognition of the restructuring pursuant to Chapter 15 under U.S. law. Mr. Bailey also serves as a Director of AgaMatrix Holdings, SCP Interventional Radiology LLC and The Homestretch Foundation, and previously served as a Director of Angiotech Pharmaceuticals, LifeCare Management Services and OncoGenex Inc. Previously, Mr. Bailey served as a Director in the health care investment banking group at Credit Suisse First Boston and Donaldson, Lufkin & Jenrette. Mr. Bailey received an A.B. in economics from Harvard University in 1990 and an M.B.A. from Harvard Business School in 1995.

What is K. Thomas Bailey's net worth?

The estimated net worth of K. Thomas Bailey is at least $0.00 as of May 26th, 2023. Mr. Bailey owns 75,388 shares of NanoString Technologies stock worth more than $0 as of April 26th. This net worth estimate does not reflect any other investments that Mr. Bailey may own. Additionally, Mr. Bailey receives a salary of $637,410.00 as CFO at NanoString Technologies. Learn More about K. Thomas Bailey's net worth.

How old is K. Thomas Bailey?

Mr. Bailey is currently 55 years old. There are 4 older executives and no younger executives at NanoString Technologies. The oldest executive at NanoString Technologies is Dr. Joseph M. Beechem Ph.D., Chief Scientific Officer and Senior VP of Research & Development, who is 66 years old. Learn More on K. Thomas Bailey's age.

What is K. Thomas Bailey's salary?

As the CFO of NanoString Technologies, Inc., Mr. Bailey earns $637,410.00 per year. The highest earning executive at NanoString Technologies is Mr. R. Bradley Gray, CEO, President & Director, who commands a salary of $1,060,000.00 per year. Learn More on K. Thomas Bailey's salary.

How do I contact K. Thomas Bailey?

The corporate mailing address for Mr. Bailey and other NanoString Technologies executives is 530 FAIRVIEW AVENUE NORTH SUITE 2000, SEATTLE WA, 98109. NanoString Technologies can also be reached via phone at (888) 358-6266 and via email at [email protected]. Learn More on K. Thomas Bailey's contact information.

Has K. Thomas Bailey been buying or selling shares of NanoString Technologies?

K. Thomas Bailey has not been actively trading shares of NanoString Technologies in the last ninety days. Most recently, on Friday, May 26th, K Thomas Bailey bought 15,000 shares of NanoString Technologies stock. The stock was acquired at an average cost of $5.76 per share, with a total value of $86,400.00. Following the completion of the transaction, the chief financial officer now directly owns 75,388 shares of the company's stock, valued at $434,234.88. Learn More on K. Thomas Bailey's trading history.

Who are NanoString Technologies' active insiders?

NanoString Technologies' insider roster includes K. Bailey (CFO), Joseph Beechem (SVP), Elisha Finney (Director), R. Gray (CEO), Robert Hershberg (Director), and Kirk Malloy (Director). Learn More on NanoString Technologies' active insiders.

Are insiders buying or selling shares of NanoString Technologies?

In the last year, NanoString Technologies insiders bought shares 3 times. They purchased a total of 80,400 shares worth more than $461,826.00. The most recent insider tranaction occured on May, 26th when CFO K Thomas Bailey bought 15,000 shares worth more than $86,400.00. Insiders at NanoString Technologies own 3.1% of the company. Learn More about insider trades at NanoString Technologies.

Information on this page was last updated on 5/26/2023.

K. Thomas Bailey Insider Trading History at NanoString Technologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/26/2023Buy15,000$5.76$86,400.0075,388View SEC Filing Icon  
12/13/2022Buy29,161$8.05$234,746.0548,533View SEC Filing Icon  
3/15/2022Sell2,110$27.81$58,679.10View SEC Filing Icon  
3/10/2022Sell5,000$33.81$169,050.00View SEC Filing Icon  
3/8/2022Sell3,058$33.06$101,097.48View SEC Filing Icon  
11/17/2021Sell7,843$46.74$366,581.82View SEC Filing Icon  
8/17/2021Sell7,845$51.98$407,783.105,938View SEC Filing Icon  
3/17/2021Sell28,613$65.63$1,877,871.1926,072View SEC Filing Icon  
11/18/2020Sell5,937$48.21$286,222.775,937View SEC Filing Icon  
8/18/2020Sell5,938$38.94$231,225.725,938View SEC Filing Icon  
6/30/2020Sell3,260$29.17$95,094.20View SEC Filing Icon  
11/12/2019Sell5,937$23.00$136,551.005,937View SEC Filing Icon  
8/6/2019Sell35,625$25.24$899,175.0035,625View SEC Filing Icon  
See Full Table

K. Thomas Bailey Buying and Selling Activity at NanoString Technologies

This chart shows K Thomas Bailey's buying and selling at NanoString Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

NanoString Technologies Company Overview

NanoString Technologies logo
NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaboration with Lam Research Corporation for the development of NGS sequencing platform and related assays; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer, as well as collaboration with Stanford Medicine, Acrobat Genomics, and Illumina Accelerator to discover new drug targets for gene editing-based therapeutics. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington. On February 4, 2024, NanoString Technologies, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $0.36
Low: $0.05
High: $0.80

2 Week Range

Now: N/A

Volume

23,061,200 shs

Average Volume

34,541,648 shs

Market Capitalization

$5.07 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.24